Stryker (SYK) Asset Writedowns and Impairment (2010 - 2025)
Stryker (SYK) reported Asset Writedowns and Impairment of $7.0 million for Q4 2025, down 99.27% year-over-year from $956.0 million in Q4 2024, and down 90.41% quarter-over-quarter from $73.0 million in Q3 2025.
Stryker (SYK) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends
Stryker (SYK) has 10 years of Asset Writedowns and Impairment data on file, last reported at $7.0 million in Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $7.0 million, down 99.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.0 million (down 86.62% YoY), and the FY2025 annual result was $170.0 million, down 82.6% from the prior year.
- Asset Writedowns and Impairment retreated to $7.0 million in Q4 2025 per SYK's latest filing, from $73.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $956.0 million in Q4 2024 and troughed at $1.0 million in Q2 2023.
- A 5-year average of $111.9 million and a median of $29.5 million in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment jumped 3883.33% in 2024, then tumbled 99.27% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $145.0 million in 2021, then surged by 73.79% to $252.0 million in 2022, then sank by 90.48% to $24.0 million in 2023, then jumped by 3883.33% to $956.0 million in 2024, then plunged by 99.27% to $7.0 million in 2025.
- Business Quant data shows SYK's Asset Writedowns and Impairment at $7.0 million in Q4 2025, $73.0 million in Q3 2025, and $55.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Jun 30, 2025 | 55.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Dec 31, 2024 | 956.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 16.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Dec 31, 2023 | 24.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Sep 30, 2023 | 9.00 Mn |